SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    M. Urowitz, D. D. Gladman, D. Ibañez, J. Sanchez-Guerrero, S. C. Bae, C. Gordon, P. R. Fortin, A. Clarke, S. Bernatsky, J. G. Hanly, D. J. Wallace, D. Isenberg, A. Rahman, J. Merrill, E. Ginzler, G. S. Alarcón, B. Fessler, M. Khamashta, K. Steinsson, M. Petri, M. Dooley, I. N. Bruce, S. Manzi, G. Sturfelt, O. Nived, R. Ramsey-Goldman, A. Zoma, P. Maddison, K. Kalunian, R. Vollenhoven, C. Aranow, J. Romero Diaz, T. Stoll, Changes in Quality of Life in the First 5 Years of Disease in a Multicenter Cohort of Patients With Systemic Lupus Erythematosus, Arthritis Care & Research, 2014, 66, 9
  2. 2
    R. Furie, M. A. Petri, V. Strand, D. D. Gladman, Z. J. Zhong, W. W. Freimuth, Clinical, laboratory and health-related quality of life correlates of Systemic Lupus Erythematosus Responder Index response: a post hoc analysis of the phase 3 belimumab trials, Lupus Science & Medicine, 2014, 1, 1, e000031

    CrossRef

  3. 3
    V. Strand, R. A. Levy, R. Cervera, M. A. Petri, H. Birch, W. W. Freimuth, Z. J. Zhong, A. E. Clarke, Improvements in health-related quality of life with belimumab, a B-lymphocyte stimulator-specific inhibitor, in patients with autoantibody-positive systemic lupus erythematosus from the randomised controlled BLISS trials, Annals of the Rheumatic Diseases, 2014, 73, 5, 838

    CrossRef

  4. 4
    Chiao-Yi Lin, Chun-Chuan Shih, Chun-Chieh Yeh, Wan-Hsin Chou, Ta-Liang Chen, Chien-Chang Liao, Increased risk of acute myocardial infarction and mortality in patients with systemic lupus erythematosus: Two nationwide retrospective cohort studies, International Journal of Cardiology, 2014, 176, 3, 847

    CrossRef

  5. 5
    Moncef Zouali, Eugene A. Uy, Belimumab Therapy in Systemic Lupus Erythematosus, BioDrugs, 2013, 27, 3, 225

    CrossRef

  6. You have free access to this content6
    Bernadet Sutanto, Davinder Singh-Grewal, H. Patrick McNeil, Sean O'Neill, Jonathan C. Craig, Julie Jones, Allison Tong, Experiences and Perspectives of Adults Living With Systemic Lupus Erythematosus: Thematic Synthesis of Qualitative Studies, Arthritis Care & Research, 2013, 65, 11
  7. 7
    A. Schmeding, M. Schneider, Fatigue, health-related quality of life and other patient-reported outcomes in systemic lupus erythematosus, Best Practice & Research Clinical Rheumatology, 2013, 27, 3, 363

    CrossRef

  8. 8
    Cindy Garris, Priti Jhingran, Damon Bass, Nicole M. Engel-Nitz, Aylin Riedel, Greg Dennis, Healthcare utilization and cost of systemic lupus erythematosus in a US managed care health plan, Journal of Medical Economics, 2013, 16, 5, 667

    CrossRef

  9. 9
    Manuel F Ugarte-Gil, Graciela S Alarcón, Is there an effective treatment for late-onset systemic lupus erythematosus?, Aging Health, 2013, 9, 4, 437

    CrossRef

  10. 10
    Chapter 12: Lupus nephritis, Kidney International Supplements, 2012, 2, 2, 221

    CrossRef

  11. You have free access to this content11
    Joan T. Merrill, Ellen M. Ginzler, Daniel J. Wallace, James D. McKay, Jeffrey R. Lisse, Cynthia Aranow, Frank R. Wellborne, Michael Burnette, John Condemi, Z. John Zhong, Lilia Pineda, Jerry Klein, William W. Freimuth, Long-term safety profile of belimumab plus standard therapy in patients with systemic lupus erythematosus, Arthritis & Rheumatism, 2012, 64, 10
  12. 12
    Irene Blanco, SLE: Serving the Underserved in an Academic Medical Center, Social Work in Health Care, 2012, 51, 7, 587

    CrossRef

  13. 13
    Anselm Mak, Catherine So-Kum Tang, Moon-Fai Chan, Alicia Ai-Cia Cheak, Roger Chun-Man Ho, Damage accrual, cumulative glucocorticoid dose and depression predict anxiety in patients with systemic lupus erythematosus, Clinical Rheumatology, 2011, 30, 6, 795

    CrossRef

  14. 14
    Sandra V Navarra, Renato M Guzmán, Alberto E Gallacher, Stephen Hall, Roger A Levy, Renato E Jimenez, Edmund K-M Li, Mathew Thomas, Ho-Youn Kim, Manuel G León, Coman Tanasescu, Eugeny Nasonov, Joung-Liang Lan, Lilia Pineda, Z John Zhong, William Freimuth, Michelle A Petri, Efficacy and safety of belimumab in patients with active systemic lupus erythematosus: a randomised, placebo-controlled, phase 3 trial, The Lancet, 2011, 377, 9767, 721

    CrossRef

  15. 15
    Brad H. Rovin, Isaac E. Stillman, Systemic Lupus Erythematosus, 2011,

    CrossRef

  16. 16
    Don Robinson, Daniel Aguilar, Melissa Schoenwetter, Robert Dubois, Simcha Russak, Rosalind Ramsey-Goldman, Sandra Navarra, Benjamin Hsu, Dennis Revicki, David Cella, Mark Hyman Rapaport, Kevin Renahan, Richard Ress, Daniel Wallace, Michael Weisman, Impact of systemic lupus erythematosus on health, family, and work: The patient perspective, Arthritis Care & Research, 2010, 62, 2
  17. 17
    Liang-Jing Lu, Daniel J. Wallace, Sandra V. Navarra, Michael H. Weisman, Lupus Registries: Evolution and Challenges, Seminars in Arthritis and Rheumatism, 2010, 39, 4, 224

    CrossRef

  18. 18
    Meenakshi Jolly, Pitfalls and Opportunities in Measuring Patient Outcomes in Lupus, Current Rheumatology Reports, 2010, 12, 4, 229

    CrossRef

  19. 19
    Andrea T. Borchers, Stanley M. Naguwa, Yehuda Shoenfeld, M. Eric Gershwin, The geoepidemiology of systemic lupus erythematosus, Autoimmunity Reviews, 2010, 9, 5, A277

    CrossRef

  20. 20
    Guillermo J. Pons-Estel, Graciela S. Alarcón, Lacie Scofield, Leslie Reinlib, Glinda S. Cooper, Understanding the Epidemiology and Progression of Systemic Lupus Erythematosus, Seminars in Arthritis and Rheumatism, 2010, 39, 4, 257

    CrossRef